JG
PHAT icon

Jain Global’s Phathom Pharmaceuticals PHAT Stock Holding History

Jain Global’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$178K Sell
16,437
-1,825
-10% -$20.8K ﹤0.01% 1545
2026
Q1 		$203K Sell
18,262
-3,475
-16% -$43.9K ﹤0.01% 1089
2025
Q4 		$361K Buy
+21,737
New +$310K ﹤0.01% 913

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Jain Global's PHAT Position: Q2 2026 in Review

Jain Global reduced its Phathom Pharmaceuticals (PHAT) stake by 10% in Q2 2026, selling an estimated $20.8K and leaving 16,437 shares worth $178K. The position accounts for ﹤0.01% of the portfolio, ranked #1545.

Jain Global first reported a position in PHAT in Q4 2025 and has held it in 3 quarters since. The position peaked at $361K in Q4 2025. 162 funds tracked by Wall St. Rank hold PHAT as of Q2 2026.

  • Jain Global held 16,437 shares of Phathom Pharmaceuticals worth $178K as of Q2 2026.
  • Jain Global sold 1,825 Phathom Pharmaceuticals shares in Q2 2026, an estimated $20.8K.
  • Phathom Pharmaceuticals made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1545 holding.
  • Jain Global first reported a position in Phathom Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Jain Global's Phathom Pharmaceuticals position peaked at $361K in Q4 2025.
  • 162 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.